• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型LSM - 83177类似物作为针对p53 - MDM2相互作用的抗结直肠癌肿瘤药物的研发。

Development of new LSM-83177 analogues as anti-tumor agents against colorectal cancer targeting p53-MDM2 interaction.

作者信息

Elgohary Mohamed K, Elkotamy Mahmoud S, Al-Warhi Tarfah, Eldehna Wagdy M, Abdel-Aziz Hatem A

机构信息

Pharmaceutical Chemistry Department, Faculty of Pharmacy, Egyptian-Russian University, Badr City, Cairo, 11829, Egypt.

Pharmaceutical Chemistry Department, Faculty of Pharmacy, Egyptian-Russian University, Badr City, Cairo, 11829, Egypt.

出版信息

Bioorg Chem. 2024 Dec;153:107766. doi: 10.1016/j.bioorg.2024.107766. Epub 2024 Aug 28.

DOI:10.1016/j.bioorg.2024.107766
PMID:39244969
Abstract

LSM-83177, a phenoxy acetic acid derivative, is a small molecule reported for its promising anti-tumor properties. Via inhibiting the interaction between MDM2 and p53, LSM-83177 can elevate the active p53 levels within cells, thereby promoting apoptosis and inhibiting tumor growth. Also, LSM-83177 has been shown to inhibit GST activity in colorectal cancer HT29 cells. In the current work, novel LSM-83177 hydrazone analogs 5a-f, 7a-b, 10a-e, and 13a-b have been designed according to the structure features of LSM-83177 and their binding mode in the active site of MDM2. The anti-cancer activity of the newly synthesized analogs is evaluated against the HT29 cell line. The most potent compounds, 7a and 10a, showed IC = 12.48 and 10.44 µg/ml, respectively, when compared with Cisplatin (IC = 11.32 µg/ml) as a reference drug. Compounds 7a and 10a were introduced for further inspection for p53-MDM2 protein-protein interaction, where they displayed IC values of 3.65 and 11.08 µg/ml, respectively. Furthermore, hydrazones 7a and 10a increased the p-53 expression levels by 3.22- and 4.25-fold, respectively; in addition, they effectively reduced the GST expression levels in HT29 cancer cells with 0.56- and 0.30-fold increments in comparison to the untreated control.

摘要

LSM - 83177是一种苯氧基乙酸衍生物,是一种据报道具有良好抗肿瘤特性的小分子。通过抑制MDM2与p53之间的相互作用,LSM - 83177可以提高细胞内活性p53水平,从而促进细胞凋亡并抑制肿瘤生长。此外,LSM - 83177已被证明可抑制结直肠癌HT29细胞中的GST活性。在当前工作中,根据LSM - 83177的结构特征及其在MDM2活性位点的结合模式,设计了新型LSM - 83177腙类似物5a - f、7a - b、10a - e和13a - b。评估了新合成类似物对HT29细胞系的抗癌活性。与作为参考药物的顺铂(IC = 11.32 µg/ml)相比,最有效的化合物7a和10a的IC值分别为12.48和10.44 µg/ml。引入化合物7a和10a进一步检测p53 - MDM2蛋白 - 蛋白相互作用,其IC值分别为3.65和11.08 µg/ml。此外,腙7a和10a分别使p - 53表达水平提高了3.22倍和4.25倍;此外,与未处理的对照相比,它们有效降低了HT29癌细胞中的GST表达水平,增量分别为0.56倍和0.30倍。

相似文献

1
Development of new LSM-83177 analogues as anti-tumor agents against colorectal cancer targeting p53-MDM2 interaction.新型LSM - 83177类似物作为针对p53 - MDM2相互作用的抗结直肠癌肿瘤药物的研发。
Bioorg Chem. 2024 Dec;153:107766. doi: 10.1016/j.bioorg.2024.107766. Epub 2024 Aug 28.
2
A structure-based virtual screening identifies a novel MDM2 antagonist in the activation of the p53 signaling and inhibition of tumor growth.基于结构的虚拟筛选鉴定出一种新型MDM2拮抗剂,可激活p53信号通路并抑制肿瘤生长。
Acta Pharmacol Sin. 2025 Mar;46(3):740-750. doi: 10.1038/s41401-024-01394-6. Epub 2024 Oct 9.
3
Novel benzenesulfonamides as dual VEGFR2/FGFR1 inhibitors targeting breast cancer: Design, synthesis, anticancer activity and in silico studies.新型苯磺酰胺类双重 VEGFR2/FGFR1 抑制剂靶向治疗乳腺癌:设计、合成、抗癌活性及计算机模拟研究。
Bioorg Chem. 2024 Nov;152:107728. doi: 10.1016/j.bioorg.2024.107728. Epub 2024 Aug 17.
4
Novel bis-benzimidazole-triazole hybrids: anticancer study, in silico approaches, and mechanistic investigation.新型双苯并咪唑-三唑杂化物:抗癌研究、计算机模拟方法及作用机制研究
Future Med Chem. 2025 Jan;17(1):93-107. doi: 10.1080/17568919.2024.2437980. Epub 2024 Dec 13.
5
Biological and In Silico Studies of a Novel Pyrazolo[3,4-d]Thiazole Derivatives: Anticancer, Anti-Inflammatory, Molecular Docking, and SAR.新型吡唑并[3,4-d]噻唑衍生物的生物学及计算机模拟研究:抗癌、抗炎、分子对接及构效关系
Chem Biodivers. 2025 Jun;22(6):e202403173. doi: 10.1002/cbdv.202403173. Epub 2025 Feb 26.
6
Design, synthesis, and biological evaluation of N-(2-amino-phenyl)-5-(4-aryl- pyrimidin-2-yl) amino)-1H-indole-2-carboxamide derivatives as novel inhibitors of CDK9 and class I HDACs for cancer treatment.N-(2-氨基苯基)-5-(4-芳基嘧啶-2-基氨基)-1H-吲哚-2-甲酰胺衍生物作为新型CDK9和I类组蛋白去乙酰化酶抑制剂用于癌症治疗的设计、合成及生物学评价
Bioorg Chem. 2025 Jul 15;162:108577. doi: 10.1016/j.bioorg.2025.108577. Epub 2025 May 10.
7
Identification of 7-aminourea or 7-aminothiourea derivatives of camptothecin as selective topoisomerase I inhibitors with anti-colorectal cancer activities.鉴定喜树碱的 7-氨基脲或 7-氨基硫脲衍生物为具有抗结直肠肿瘤活性的选择性拓扑异构酶 I 抑制剂。
Bioorg Chem. 2024 Nov;152:107723. doi: 10.1016/j.bioorg.2024.107723. Epub 2024 Aug 13.
8
Novel indole Schiff base β-diiminato compound as an anti-cancer agent against triple-negative breast cancer: In vitro anticancer activity evaluation and in vivo acute toxicity study.新型吲哚席夫碱β-二亚胺化合物作为一种针对三阴性乳腺癌的抗癌剂:体外抗癌活性评价和体内急性毒性研究。
Bioorg Chem. 2024 Nov;152:107730. doi: 10.1016/j.bioorg.2024.107730. Epub 2024 Aug 16.
9
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
10
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.

引用本文的文献

1
p53 in colorectal cancer: from a master player to a privileged therapy target.p53与结直肠癌:从主导因素到优先治疗靶点
J Transl Med. 2025 Jun 19;23(1):684. doi: 10.1186/s12967-025-06566-4.